The Fort Worth Press - Decade since Ebola, Sierra Leone fights another deadly fever

USD -
AED 3.672979
AFN 67.991622
ALL 93.135443
AMD 395.970165
ANG 1.802053
AOA 910.981986
ARS 1009.500099
AUD 1.537314
AWG 1.8
AZN 1.701175
BAM 1.853567
BBD 2.018746
BDT 119.480076
BGN 1.852495
BHD 0.376974
BIF 2953.948803
BMD 1
BND 1.343904
BOB 6.908905
BRL 6.015199
BSD 0.999848
BTN 84.428754
BWP 13.65898
BYN 3.271635
BYR 19600
BZD 2.015353
CAD 1.40105
CDF 2869.99959
CHF 0.882145
CLF 0.035442
CLP 977.940354
CNY 7.243402
CNH 7.24744
COP 4418.21
CRC 510.633458
CUC 1
CUP 26.5
CVE 104.50173
CZK 23.935903
DJF 178.050514
DKK 7.06288
DOP 60.371708
DZD 133.504987
EGP 49.594503
ERN 15
ETB 123.865385
EUR 0.947099
FJD 2.26715
FKP 0.789317
GBP 0.787715
GEL 2.735031
GGP 0.789317
GHS 15.447894
GIP 0.789317
GMD 70.99991
GNF 8616.784343
GTQ 7.714689
GYD 209.117187
HKD 7.783755
HNL 25.296757
HRK 7.133259
HTG 131.083374
HUF 391.124986
IDR 15865
ILS 3.651101
IMP 0.789317
INR 84.47375
IQD 1309.791211
IRR 42074.999887
ISK 137.219729
JEP 0.789317
JMD 157.532104
JOD 0.709298
JPY 150.903498
KES 129.702159
KGS 86.799799
KHR 4029.835186
KMF 466.502086
KPW 899.999621
KRW 1394.369738
KWD 0.30751
KYD 0.833262
KZT 512.036089
LAK 21943.79946
LBP 89535.331135
LKR 290.647864
LRD 179.475515
LSL 18.168903
LTL 2.95274
LVL 0.60489
LYD 4.877979
MAD 10.005734
MDL 18.307697
MGA 4668.530541
MKD 58.260104
MMK 3247.960992
MNT 3397.999946
MOP 8.014937
MRU 39.884377
MUR 46.534506
MVR 15.44968
MWK 1733.781927
MXN 20.449705
MYR 4.440557
MZN 63.893159
NAD 18.16942
NGN 1686.149838
NIO 36.790629
NOK 11.043699
NPR 135.086007
NZD 1.69591
OMR 0.384993
PAB 0.999858
PEN 3.751961
PGK 4.031635
PHP 58.726502
PKR 277.954528
PLN 4.078646
PYG 7797.906469
QAR 3.644506
RON 4.713599
RSD 110.755001
RUB 108.000549
RWF 1391.77163
SAR 3.756598
SBD 8.39059
SCR 13.653774
SDG 601.498176
SEK 10.92436
SGD 1.34159
SHP 0.789317
SLE 22.695873
SLL 20969.504736
SOS 571.398785
SRD 35.404994
STD 20697.981008
SVC 8.748519
SYP 2512.529858
SZL 18.176907
THB 34.397226
TJS 10.898356
TMT 3.51
TND 3.158493
TOP 2.342098
TRY 34.6749
TTD 6.794295
TWD 32.521401
TZS 2645.611015
UAH 41.581955
UGX 3689.505333
UYU 42.828034
UZS 12862.626167
VES 47.254389
VND 25373
VUV 118.722009
WST 2.791591
XAF 621.680638
XAG 0.033091
XAU 0.000379
XCD 2.70255
XDR 0.764835
XOF 621.6718
XPF 113.026048
YER 249.924998
ZAR 18.094497
ZMK 9001.201852
ZMW 26.970317
ZWL 321.999592
  • RELX

    0.2400

    47.05

    +0.51%

  • NGG

    0.5000

    63.33

    +0.79%

  • GSK

    0.3100

    34.33

    +0.9%

  • RIO

    0.2900

    62.32

    +0.47%

  • RBGPF

    1.0000

    62

    +1.61%

  • RYCEF

    0.1100

    6.91

    +1.59%

  • BTI

    0.2300

    37.94

    +0.61%

  • VOD

    0.1100

    8.97

    +1.23%

  • CMSC

    -0.0500

    24.52

    -0.2%

  • AZN

    0.8400

    67.2

    +1.25%

  • BP

    0.1700

    29.13

    +0.58%

  • SCS

    -0.0700

    13.47

    -0.52%

  • BCC

    -2.0100

    146.4

    -1.37%

  • BCE

    0.3900

    27.02

    +1.44%

  • CMSD

    -0.0700

    24.36

    -0.29%

  • JRI

    0.1700

    13.41

    +1.27%

Decade since Ebola, Sierra Leone fights another deadly fever
Decade since Ebola, Sierra Leone fights another deadly fever / Photo: © AFP

Decade since Ebola, Sierra Leone fights another deadly fever

Rummaging in the darkness of a tiny mud and thatch home in eastern Sierra Leone, ecologist James Koninga plucks a metal rat trap from under a collapsed bedframe.

Text size:

The 62-year-old belongs to a group of researchers tracking the deadly Lassa fever, a viral haemorrhagic illness endemic in several West African countries and transmitted by infected rats.

Koninga knows all too well what is at stake -- he spent a gruelling 20 days in hospital with a Lassa-induced fever, headache and diarrhoea as a young researcher 30 years ago.

"I thought I was going away, I was going to die," he said.

Ten years ago, the haemorrhagic Ebola virus devastated this region, killing over 11,000 people across Guinea, Sierra Leone and Liberia.

Sierra Leone has not recorded an Ebola case since the outbreak ended in 2016, thanks partly to a vaccine rollout.

In Kenema district, an early Ebola epicentre, scientists are using the lessons learned a decade ago to try to stop Lassa fever in its tracks.

With an overall fatality rate of one percent, Lassa is nowhere near as deadly as Ebola, which kills on average 50 percent of sufferers, according to the World Health Organization.

But one in five Lassa infections can result in severe illness with a fatality rate of 15 percent.

While cases have largely plateaued in Sierra Leone, researchers are seeing a spread beyond traditional Lassa hotspots.

There is no licensed vaccine and only limited treatment, with the scars of Ebola preventing many from seeking early life-saving help.

- Living with rats -

Monitoring the rodent population is crucial in remote villages like Mapuma, where some 20 houses lie enveloped by dense forest.

"Rats burrow inside the houses for shelter," explained Koninga, donning a face shield and gloves.

Humans usually contract Lassa virus after having contact with the urine, saliva or droppings of infected rats.

"If people come in from the bush with cuts on them and lie on the bed, they could be infected."

Proximity to the forest, rudimentary mud construction, and uncovered grain and water storage make the dwellings "five-star hotels" for rats, said Lansana Kanneh, 58, field supervisor at the region's Kenema Government Hospital (KGH).

"Food is scarce for these people so sometimes they even eat the food that has been partially eaten by the rodent," he added.

Trappers can find up to 20 rats per day in some villages.

After identifying if the rodents are the Lassa-carrying Mastomys variety, samples are collected for analysis.

The rats then receive an injection that prevents viral transmission before being released.

Lassa virus infects between 100,000 and 300,000 people annually in West Africa, killing roughly 5,000, according to the Africa Centres for Disease Control and Prevention.

But the figures likely underestimate the true scale given surveillance challenges.

Admissions to the Lassa unit at KGH -- Sierra Leone's only dedicated treatment centre -– have declined in the past decade.

Patients normally arrive in the 14-bed isolation ward during the dry season from November to May, but this once-predictable pattern is increasingly uncertain.

- 'Lassa blood' -

"Now we see cases year-round," said Donald Grant, head of the KGH Lassa fever programme.

The team are also noticing Lassa beyond traditionally endemic zones, with Grant suspecting an improvement in testing as well as deforestation driving rodents into closer contact with humans.

Over the past decade, KGH has also seen an alarming uptick in Lassa patient mortality, which now stands at over 50 percent.

"We've seen a lot of these cases coming in in their late stages," said Kanneh.

"Sometimes they only spend 24 to 48 hours in the hospital, and they die."

Rapid detection is the key to survival, but non-specific febrile symptoms mean Lassa is commonly misdiagnosed as malaria, cholera or typhoid.

Hours-long journeys on dirt roads prevent many from seeking treatment.

As does the trauma from Ebola, which killed some 4,000 Sierra Leoneans.

"The community people thought that Ebola was brought by the health workers," Kanneh said, explaining that a lingering mistrust contributed to reduced admissions.

A KGH team raises awareness in local communities about seeking rapid help and ensuring good domestic hygiene.

It is a message well-received by Musa Mosoh, a 53-year-old Lassa survivor who lost seven family members to the illness.

As the morning rain fell in his village of Panguma -- a Lassa red zone -- Mosoh recalled how his family had faced stigma from the community.

"Now... people have got the understanding we are not from Lassa blood, it's just a sickness."

Mosoh tells those with a continuous fever or headache to go straight to the hospital, and even keeps cats to repel any virus-carrying rodents.

Grant, the doctor, is hopeful of a vaccine in the next few years.

Participants in Nigeria and Liberia are currently being given the first-ever Lassa vaccine to reach phase two trials -- the midway point of testing in humans.

But Grant still urges caution.

Ebola "taught us a lesson that we need not wait until that critical moment that it overwhelms all of us," he said.

"We need to act now."

S.Jordan--TFWP